Literature DB >> 19864669

Treatment of musical hallucinosis with acetylcholinesterase inhibitors.

M Strauss, H-J Gertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19864669     DOI： 10.1136/jnnp.2008.160978

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

Review 1.  Central auditory disorders: toward a neuropsychology of auditory objects.

Authors:  Johanna C Goll; Sebastian J Crutch; Jason D Warren
Journal:  Curr Opin Neurol       Date:  2010-12       Impact factor: 5.710

2.  [Acoustic hallucinations and pseudo-hallucinations in acquired deafness: antipsychotic treatment].

Authors:  F Bernard; A Quante
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

Review 3.  Oxymorphone insufflation associated with acute sensorineural hearing loss: case files of the University of Massachusetts medical toxicology fellowship.

Authors:  Katherine L Boyle; Christopher D Rosenbaum
Journal:  J Med Toxicol       Date:  2013-06

Review 4.  Musical hallucinations: review of treatment effects.

Authors:  Jan A F Coebergh; R F Lauw; R Bots; I E C Sommer; J D Blom
Journal:  Front Psychol       Date:  2015-06-16

5.  Musical hallucinations treated with acetylcholinesterase inhibitors.

Authors:  Jan Dirk Blom; Jan Adriaan F Coebergh; René Lauw; Iris E C Sommer
Journal:  Front Psychiatry       Date:  2015-04-07       Impact factor: 4.157

6.  Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.

Authors:  Qingwei Ruan; Zhuowei Yu; Weibin Zhang; Jian Ruan; Chunhui Liu; Ruxin Zhang
Journal:  Front Aging Neurosci       Date:  2018-04-06       Impact factor: 5.750

7.  Those Who Hear Music: Three Cases on Musical Hallucinations.

Authors:  Yasira Doluweera; Chathurie Suraweera
Journal:  Case Rep Psychiatry       Date:  2018-06-27

8.  Musical hallucinations and their relation with epilepsy.

Authors:  J A F Coebergh; R F Lauw; I E C Sommer; J D Blom
Journal:  J Neurol       Date:  2019-04-10       Impact factor: 4.849
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.